940 shaares
The suit claims that the Food and Drug Administration lacked the authority to approve mifepristone, did not adequately study it and that the drug is unsafe.
The suit claims that the Food and Drug Administration lacked the authority to approve mifepristone, did not adequately study it and that the drug is unsafe.
